DAFNA Capital Management LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1389933
LOS ANGELES, CA
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,302,820
-$712,505 QoQ
Shares Held
70,615
0.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
2.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DAFNA Capital Management LLC holds $21,126,826 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (44.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
70,615 | $9,302,820 | |
| 2 | ALKS |
Alkermes plc.
|
139,482 | $4,932,083 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
430,248 | $4,095,960 | |
| 4 | AQST |
Aquestive Therapeutics, Inc.
|
368,415 | $1,528,922 | |
| 5 | SCYX |
Scynexis Inc
|
1,086,956 | $996,738 | |
| 6 | ADCT |
ADC Therapeutics SA
|
72,081 | $270,303 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,302,820 | 70,615 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,015,325 | 70,615 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,912,933 | 70,615 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,875,599 | 70,615 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,920,619 | 71,615 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,775,447 | 71,615 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,021,040 | 69,615 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,859,237 | 71,615 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,877,140 | 71,615 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,567,752 | 72,615 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,281,687 | 73,615 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,036,194 | 74,615 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,552,530 | 74,615 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,733,572 | 73,121 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,513,262 | 80,155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,057,209 | 82,655 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,842,656 | 83,655 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,124,896 | 83,655 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,119,261 | 84,655 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,168,104 | 73,655 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,162,948 | 73,655 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,838,136 | 92,208 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,674,401 | 90,208 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $8,931,376 | 73,208 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,942,002 | 80,208 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||